Prostate cancer is among the top cancers diagnosed annually in the world and yet we know little about how to discriminate the disease that will kill from that that will be so slow growing that a man need not have his disease treated.
Protecting the public from cancer often requires knowledge about carcinogens, including tests for determining carcinogenicity.
As the world transitions to a preponderance of chronic conditions, including cancer, as leading cause of premature death, international public health will be challenged to adopt strategies for reducing population cancer burden. Affordability, access to health professionals and understanding the local context for cancer development are important.
Incorporating CAM (Complimentary Alternative Medicine) practices into conventional therapy has been met with uneasy suspicion by some. It is important to say that integrative medicine is not a rejection of conventional medicine, nor does it uncritically embrace all alternative practices.
Translational research is scientific research that facilitates the translation of findings from basic science to practical applications that enhance human health and well-being.
Many adolescents and youth are likely to adopt behaviors that are very common among adults some time during their transition to full adulthood, even when they are aware of the undesireable health consequences of these behaviors. Smoking is still the behavior that contributes most to premature loss of life.
Biomarkers play an important role in understanding the relationships between exposure to environmental chemicals and therapies, the development of chronic human diseases, and the identification of subgroups that are at increased risk for disease.
Recent estimates of tobacco control scenarios estimate about a third of lung cancers can be avoided with no uptake of smoking.
Focus on the majority of cancers, breast, prostate, colon, and lung, is highly oriented to secondary prevention and the use of screening in healthy populations (breast and colon), clinical care (prostate), or high risk populations (lung). Low rates of cervical cancer is a screening success story.
Among the nations of the world, the U.S. ranks 50th in life expectancy and is declining. Even the well-insured often get substandard care. Medical gluttony is the inappropriate use and overuse of medical treatment that adds to the unnecessary cost to health care, and can actually be harmful to the individual.
HPV-associated disease is important global cause of mortality and morbidity. It is one of the most common STD infections.
Cancer Prevention & Control News Feed
Notice: Funding for Prostate Cancer Research
Funding is available to support multidisciplinary research (co-principal investigators [PI] from different disciplines) in prostate cancer through the Patrick C. Walsh Prostate Cancer Research Fund. Awards are a maximum of $100,000 and should not be used to support PI salary. Partnership with a Brady Urological Institute faculty member is highly encouraged. Emphasis will be placed on funding high-risk/high-reward research. Faculty whose laboratories received an award through the fund in the last three years are not eligible for funding.
Kenneth J. Pienta, M.D., Selected as Director of Prostate Cancer Program
Kenneth J. Pienta, M.D., has been selected as the director of our Prostate Cancer Program. He is joined by two co-directors, Samuel R. Denmeade, M.D. and Shawn E. Lupold, Ph.D.
In his new role, Ken will facilitate the growth and development of our prostate and other GU cancer research activities. Ken is a Professor of Urology and Oncology and brings considerable previous leadership experience from the University of Michigan Medical School in Ann Arbor where he held positions as Director of Urologic Oncology and Associate Dean for Clinical and Translational Research.
Sam, whose clinical and basic science research has focused on the bringing promising new therapies to patients with prostate cancer, will continue his translational research efforts conducting innovative clinical trials through his clinical practice and developing new therapeutics in the lab.
Shawn is an Associate Professor of Urology, Oncology and Radiation Oncology and Molecular Radiation Sciences and his research focuses on prostate cancer biology with the goal of exploiting prostate and cancer tissue-specificity to develop new diagnostic, prognostic, and therapeutic agents.
2014 ASPO Conference American Society of Preventive Oncology 38th Annual Meeting March 8-11, 2014
American Society of Preventive Oncology
38th Annual Meeting
March 8-11, 2014
Hyatt Regency Crystal City
Vaccine Used to Treat Cervical Precancers Triggers Immune Cell Response
Preliminary results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself. The Johns Hopkins scientists who conducted the trial said the finding is significant because measuring immune system responses directly in the lesions may be a more accurate way to evaluate so-called "therapeutic" vaccines than by the conventional means of blood analysis.
An Update from the Sidney Kimmel Comprehensive Cancer Center on its Maryland Cigarette Restitution Funds
The Maryland Cancer Registry
Diane Dwyer and Cliff Mitchell describe the Maryland Cancer Registry and the data it collects. They also discuss the differences between the registry's data and information gathered by community members.
Psychology's Role in Smoking Decline Continues 50 Years After Surgeon General's Groundbreaking Report - Five questions for psychologist David B. Abrams, PhD
Fifty years ago, the U.S. Surgeon General’s Report on Smoking and Health prompted one of the largest public health behavior change success stories of the 20th century. Before and since this groundbreaking report’s release, psychology has been at the forefront of smoking cessation efforts.
Vote for the "Cancer Matters" Blog!
The Cancer Matters blog has been nominated for a Mobbie – a Baltimore Sun award for best blog among “Best Organization Blogs”. You can vote for the next couple days.
NCI Research to Reality Cyber-Seminar
Using New/Social Media for Cancer Control and Prevention
Workshops on NIH/NCI Grants for Graduate Students, Post Graduates and Early Investigators
The Johns Hopkins Center to Reduce Cancer Disparities of the Sidney Kimmel Comprehensive Cancer Center and the Professional Development Office Johns Hopkins Medical Institutions are hosting two different workshops on NIH/NCI grants for graduate/post graduate students and early investigators. Please use the following link to register.
For more information, please contact:
Ahmed Elmi, MPH, CHES
Community Relations Manager
Panel recommends revised cancer warning on consent form for indoor tanning
An advisory panel recommended Friday that the state Health Department revise language on its parental consent form for indoor tanning to specify that the practice can cause skin cancer.
Read more: http://www.baltimoresun.com/health/bs-hs-tanning-warning-20130927,0,1818920.story#ixzz2iUNxBVLB
CRF Cancer Grant Solicitation
The Cigarette Restitution Fund (CRF) research grant to Johns Hopkins will be funding faculty recruitment (within one year of appointment) and translational research project proposals in fiscal year 2014. Funded awards will begin on July 1st and end June 30th 2014.
Transforming Prostate Cancer
Detection, Diagnosis and Treatment - everything you need to know about prostate cancer.
The Coffey Way
This icon of cancer research shares his unlikely journey from the hills of Bristol Tennessee to Johns Hopkins Leadership
Johns Hopkins diabetes expert Fred Brancati dies at 53
He was director General Internal Medicine division at School of Medicine
Just Released! FY13 DoD ARP, BCRP, OCRP, PCRP, PRMRP Program
Recently released funding opportunities from these five Department of Defense (DoD) Research Programs:
Autism Research Program (ARP)
Breast Cancer Research Program (BCRP)
Ovarian Cancer Research Program (OCRP)
Prostate Cancer Research Program (PCRP)
Peer Reviewed Medical Research Program (PRMRP)
Johns Hopkins Oncologist Vogelstein Receives $3 million Life Sciences Award
Bert Vogelstein, a professor of oncology and pathology at Johns Hopkins and a pioneer in the field of cancer genomics, is among 11 scientists named the first winners of the world's richest academic prize for medicine and biology.
NSF recognizes JHU Professor for Cancer Treatment Research
Cui Receives CAREER Award for Work Involving Cancer-fighting Nanostructures
JHU Researchers Personalize Chemotherapy Drug Selection
Test uses cells from patients' tumors to help determine best treatment
HERA Women’s Cancer Foundation Ovarian Cancer Outside-the-Box (OSB) Seed Grant for 2013
The purpose of the OSB grant is to improve prevention and prognosis through innovative scientific research and to foster a strong long-term commitment to research in the field of ovarian cancer.
Hope for Early Test for Female Cancers
"This is really something that can be done as part of routine medical care," said Dr. Luis Diaz, lead researcher on the study.
New Tobacco Quitline Services for New Year, New Smoke-free Life Text support, 24/7 counseling among enhanced free services
The Maryland Department of Health and Mental Hygiene (DHMH), Center for Tobacco Prevention and Control (CTPC) today announced new services for the Maryland Tobacco Quitline
How Aggressive is the Cancer? Study of Telomeres May Lead to New Test
Alan Meeker and Elizabeth Platz: Telomeres, tiny regions at the ends of chromosomes,
get a bit shorter every time a cell divides. When they get too short, this can lead to cancer.
Guidelines limiting prostate cancer screening are widely ignored
Guidelines limiting PSA screening for prostate cancer detection in older men are widely ignored, researchers said Tuesday, and physicians seem likely to continue to ignore them. Craig E. Pollack is quoted.
An Update from the SKCCC on its Maryland Cigarette Restitution Funds- 2012
Continued Progress Hinges on the Return to Full CRF Funding
A Partnership in Cancer Prevention
Dr. John Groopman discusses the partnership between SKCCC, Howard University and the MD CRF.
John Groopman Discusses Phase 0 Cancer Prevention Trials
Cancer Prevention and Control expert John Groopman discusses natural methods to thwart cancer.
Biomarkers predict who may need prostate treatment
A blood test for certain forms of prostate specific antigen, or PSA, and measurement of DNA content in biopsy tissue accurately predict which men with potentially nonlethal prostate cancers may eventually need treatment, say Johns Hopkins scientists.
An Update on the Maryland Cigarette Resitiution Fund
Interview with John Groopman
Dr. Groopman talks about his landmark work in the field of hepatocellular carcinoma and the role of aflotoxins in the induction of this devastating liver cancer.
Heart drug may lead to prostate cancer treatment - Baltimore Sun
Elizabeth Platz, CRF investigator, quoted in Baltimore Sun
Surprise Finding: Pancreatic Cancers Progress to Lethal Stage Slowly
Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.
Hear from CRF investigators
Young up and coming investigators and clinicians represent the future of cancer research and treatment.
YouTube Videos featuring CRF investigators
You Tube Videos (scan down for videos on CRF investigators Vasan Yegnasubrumanian and Sarah Wheelan.
Ten Big Stories of the Maryland CRF
CRF Research Grants Fill an Unmet Funding Need
Maryland Cigarette Restitution Fund Scientific Report is now available!
Please click on the attached PDF to view the report.
CPC Events Calendar
What's Happening This Week
CPC Program Activity
CRF Cancer Grant Solicitation
FY14 Application for Funding
Maryland Comprehensive Cancer Control Plan
Maryland Comprehensive Cancer Control Plan
Report Your Cancer Prevention and Control Activities
Want to stay informed of what's going on with our group? Then join our mailing list. Just add your email address below to start receiving our notifications.